Event Description

Name: COVID-19 and What Multiple Myeloma Patients Need to Know
Start: 2020-03-23T11:00:00-06:00
End: 2020-03-23T12:00:00-06:00

Joshua Richter, MD
Tisch Cancer Institute, Mount Sinai
Interview Date: March 20, 2020

The coronavirus is on the minds of global citizens and all myeloma patients. Dr. Joshua Richter shares an incredible amount of information for myeloma patients to navigate their care in these uncertain times. He shares drugs patients may want to ask their doctors about, considerations for stem cell transplant, the status of some myeloma clinical trials, tradeoffs of using IVIG, and potential therapies being used to treat the coronavirus. This is a must-read show to learn how the coronavirus is affecting myeloma patients and how they can be prepared.

Thanks to our episode sponsor

Bristol Myers-Squibb

Schedule & Agenda

Discussion

11:00AM

Dr. Joshua Richter & Jenny Alhstrom

11:00AM

Dr. Joshua Richter & Jenny Alhstrom

Discussion

Speakers & Moderators

Joshua Richter, MD

Joshua Richter, MD, is Associate Professor of Medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology. He is the director of Multiple Myeloma at the Blavatnik Family- Chelsea Medical Center at Mount Sinai. Dr. Richter treats patients with plasma cell dyscrasias, including multiple myeloma and related diseases such as AL amyloidosis, plasma cell leukemia, and Waldenstrom’s Macroglobulinemia. Dr. Richter has extensive experience with clinical trials focused on novel therapies, including antibody therapy and immunotherapy for a precision medicine approach. He has published extensively on these topics and has been invited to speak regionally, nationally, and also internationally. He has been published in journals such as the New England Journal of Medicine, Blood, and the Journal of Clinical Oncology.

Read Bio

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio